We bring you the latest news on what’s happening in medicine and the pharmaceutical industry through the RSS feed of the Federal Office of Health and Swissmedic, the Swiss Agency for Therapeutic Products.
Disclaimer on External Links
Certain websites which can be accessed from this site or which lead you to this site have been set up or are used by bodies other than T.E.A.M. Pharma SA, and they have sole responsibility for the working and the content (as well as the right to supply such content) of their respective sites. It may be that these external sites are only available in English. Links to or from this site do not imply that T.E.A.M. Pharma SA supports the organisations nor that we guarantee their content (including their right to post the content) on their respective sites.
T.E.A.M. Pharma SA cannot be held responsible in any way for any link to an external site, its working and its content (including the right to provide such content) or the information, interpretation, comments or opinions which may be included. Any comments and/or requests for information on the content of an external site must be addressed to the body responsible for that site or for posting its content.
This applies to all links and internet banners which appear on this site.
There are no translations available.
Génériques : Mylan grappille des parts de marché en Franc: Le numéro un des médicaments génériques en France, qui détient près d'un tiers du marché, a amélioré ses ventes de 15 %, à 754 millions d'euros...09/04/10 Tous droits réservés (2010) LES ECHOS